Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

NCT00654225 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2340

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Dyslipidaemia

Interventions

DRUG: Rosuvastatin
DRUG: Atorvastatin

Sponsor

AstraZeneca